what happens when you stop taking compounded semaglutide is not the same as FDA-approved. The FDA has documented dosing errors and hospitalizations linked to these products. Dr. Jen Ashton breaks down the risks. Always consult your physician before What to Expect When You
Description
Our medical team will review your information to ensure this therapy is appropriate for your specific health needs and goals

What the Data Shows The SURMOUNT-1 trial, published in the New England Journal of Medicine in 2022, randomized 2,539 adults with obesity to tirzepatide at 5, 10, or 15 mg weekly or placebo for 72 weeks (3)

Call ProCare Wellness Institute at (912) 303-8996 to schedule a medically supervised GLP- 1 weight loss consultation today

Any microdosing should be done under supervision with your provider and appropriate lab work, says DeGore

Health Canada Timeline Health Canada often reviews in parallel with the FDA and can approve a drug 6 to 12 months after US approval

COA verification, batch testing, and storage matter
